News and Events

University of Florida Pathology Laboratories will be open for limited services on Labor Day, Monday, September 4th, 2017.

Normal laboratory operations will resume on Tuesday, September 5th, 2017.

FedEx will be CLOSED on Monday, September 4th, 2017 in observance of the holiday. No package deliveries will occur on Monday.

If you draw and process any AlloMap samples on Monday, September 4th, 2017, please maintain samples at -15 degrees centigrade or colder and ship on Tuesday, September 5th, 2017 for delivery on Wednesday, September 6th, 2017.

Effective immediately, Levetiracetam (Keppra) testing is now available at the University of Florida Health Pathology Laboratories Clinical Toxicology Laboratory.

Effective immediately, University of Florida Health Pathology Laboratories' service for diagnosing primary ciliary dyskinesia (PCD) is discontinued. The modern, state-of-the-art method for diagnosing or excluding this condition involves a panel of several different diagnostic methods, including nasal nitric oxide measurements, functional ciliary beat frequency by video imaging, immunofluorescence testing for specific ciliary proteins, electron microscopy (EM)  and gene sequencing.

As of December 2016, we have retired our test for Gestational Trophoblast Disease Evaluation (Partial vs. Complete Mole) [p57 Immunohistochemistry (IHC), DNA Ploidy by Flow Cytometry]. We still, however, offer p57 IHC staining.

If you have any questions about this change, please call our Client Services team at 352.265.9900 (local) or 888.375.LABS (5227).

On Saturday, November 5, University of Florida Health Pathology Laboratories began using a new, enhanced laboratory information system (LIS) that will ultimately improve our services. Since we activated our new LIS, however, we have been implementing solutions for issues that were identified on the initial launch weekend.

We added the following tests to our Test Directory in 2015:

After many months since it was first announced, the October 1, 2015, deadline for medical practices to adopt ICD-10 diagnosis codes is quickly approaching. University of Florida Health Pathology Laboratories is diligently working to understand and adopt these changes, so it is ready in time for the upcoming transition deadline.

To:  All involved in patient care

From:

Petr Starostik, MD
Molecular Pathology Director
UF Health Pathology Laboratories

Robert W. Allan, MD
Medical Director
UF Health Pathology Laboratories

Shipping renal, muscle or nerve biopsies to UF Health Pathology Laboratories is now easier than ever, thanks to three new specimen collection and handling tutorial videos we developed for our clients.

Starting April 6, 2015, UF Health Pathology Laboratory at Rocky Point in collaboration with the UF Health Personalized Medicine Program is pleased to offer CYP2D6 genetic testing.

About Us